Latest 10-Q quarterly reports

Kroger reported Q1 2026 net earnings of $903 million, supported by a 13% increase in eCommerce sales and strong operational execution.

ZRCN Inc. reports a net loss of $2.5 million for the six months ended September 30, 2025, amid significant tariff-related margin pressure and ongoing liquidity challenges.

Hudson Acquisition I Corp. reports a net loss of $86,519 for Q1 2026 as it continues to pursue a business combination with Aiways Automobile Europe GmbH.

Kinetic Seas reports Q1 2026 financial results, highlighting a net loss of $1.38 million driven by non-cash debt extinguishment charges.

Carnival Corporation reports Q2 2026 net income of $537 million and completes its dual-listed company unification and redomiciliation to Bermuda.

NaturalShrimp reports its financial status under liquidation basis following the transfer of substantially all assets to creditors.

Aperture AC reports its Q1 2026 financial status as a pre-revenue blank check company following its May 2026 IPO.

BlackBerry reported Q1 fiscal 2027 revenue of $152.9 million, exceeding expectations driven by strong QNX and SecuSUITE performance.

McCormick & Company reported 16.7% net sales growth in Q2 2026, driven by the consolidation of McCormick de Mexico and ongoing strategic integration efforts.

Amanat Acquisition Corp reports its Q1 2026 financial results as a pre-revenue blank check company following its May 2026 IPO.

Winnebago Industries reported a 9.9% decline in quarterly revenue to $698.7 million, driven by lower unit volumes in the Towable RV and Marine segments.

H.B. Fuller reports strong Q2 2026 revenue growth and announces a definitive agreement to acquire Advanced Medical Solutions Group plc.

Cluster Group Holdings reports no revenue and a net loss of $6,398 for the first quarter of 2026 as it continues to seek a business combination.

Acuity Inc. reports strong Q3 2026 growth driven by the Intelligent Spaces segment and successful integration of QSC.

The 21Shares Hyperliquid ETF (THYP) reports no operational activity for the quarter ended March 31, 2026, following the redemption of initial seed shares.

Sui Group Holdings Limited filed an amendment to its Q1 2026 Form 10-Q to correct a hyperlink in the exhibits section.

CarMax reports Q1 fiscal 2027 net earnings of $185.6 million, reflecting a 11.8% year-over-year decline amid ongoing strategic restructuring.

NOVAGOLD reports Q2 2026 financial results, highlighting continued progress on the Donlin Gold Bankable Feasibility Study and a strong liquidity position of $370.2 million.

CNBX Pharmaceuticals reports a net loss of $154,165 for the third quarter of 2026 as it continues to develop its oncology drug candidate, RCC-33.

Accenture plc announced its third quarter fiscal year 2026 financial results, reporting a 6% increase in revenue to $18.7 billion and a 9% rise in diluted earnings per share to $3.80.

Kindcard, Inc. filed its Q1 2026 Form 10-Q, reporting a decrease in revenue and an increase in net loss, while highlighting ongoing efforts to secure additional funding.

Odyssey Therapeutics, Inc. filed its Q1 2026 Form 10-Q, detailing a net loss of $38.3 million and cash reserves of $175.7 million, while advancing its lead drug candidates OD-001 and OD-002.

Skkynet Cloud Systems reports a 4% revenue increase in Q2 2026 but an 18% decrease for the six-month period, alongside a widening net loss.

Satellogic Inc. has filed an amendment to its Q1 2026 Form 10-Q, primarily to re-file Section 302 certifications with a minor text correction.

Charlton Aria Acquisition Corporation reports net income of $699,872 for Q1 2026, driven by trust account interest, while continuing its search for a business combination.

VitaSpring Biomedical reports a net loss of $75,844 for Q1 2026, with substantial doubt cast on its ability to continue as a going concern due to a significant working capital deficit and minimal cash reserves.

VitaSpring Biomedical's Q3 2025 report highlights significant financial challenges, including a substantial working capital deficit and a material weakness in internal controls, raising substantial doubt about its ability to continue as a going concern.

VitaSpring Biomedical's Q2 2026 report highlights significant financial challenges, including a severe working capital deficit and minimal cash, raising substantial doubt about its ability to continue as a going concern.

Innovative Designs, Inc. reported Q2 2026 results with increased revenues driven by House Wrap sales, but a significant rise in SG&A expenses impacted operating income.

Vynleads, Inc. reported a net loss of $96,956 for Q1 2026, an increase from $80,970 in Q1 2025, driven by higher operating expenses.